Literature DB >> 8306323

Frequent loss of chromosome 9 in human primary non-small cell lung cancer.

A Merlo1, E Gabrielson, F Askin, D Sidransky.   

Abstract

We analyzed the pattern of allelic loss on chromosome 9 in 40 primary human non-small cell lung cancers including 16 squamous cell, 18 adeno-, and 6 large cell carcinomas. Using 24 polymorphic microsatellite markers spanning chromosome 9, we found that 27 of 40 (67.5%) of these neoplasms displayed loss of heterozygosity (LOH) on chromosome 9. Most tumors showed LOH for all informative markers on both chromosomal arms, whereas five tumors demonstrated partial LOH on chromosome 9. In four of these tumors, allelic loss was limited to the 9p arm, whereas in the remaining specimen, LOH extended from 9p21-22 to terminal 9q. These five tumors delineate a minimal area of loss at 9p21-22, which includes a previously defined tumor suppressor gene locus. We have identified a distinct region of loss on chromosome 9p commonly involved in non-small cell lung cancer tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8306323

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  15 in total

1.  Genome-wide association study of prognosis in advanced non-small cell lung cancer patients receiving platinum-based chemotherapy.

Authors:  Lingmin Hu; Chen Wu; Xueying Zhao; Rebecca Heist; Li Su; Yang Zhao; Baohui Han; Songyu Cao; Minjie Chu; Juncheng Dai; Jing Dong; Yongqian Shu; Lin Xu; Yijiang Chen; Yi Wang; Feng Lu; Yue Jiang; Dianke Yu; Hongyan Chen; Wen Tan; Hongxia Ma; Jiaping Chen; Guangfu Jin; Tangchun Wu; Daru Lu; David C Christiani; Dongxin Lin; Zhibin Hu; Hongbing Shen
Journal:  Clin Cancer Res       Date:  2012-08-07       Impact factor: 12.531

2.  CDKNA2A mutation analysis, protein expression, and deletion mapping of chromosome 9p in conventional clear-cell renal carcinomas: evidence for a second tumor suppressor gene proximal to CDKN2A.

Authors:  P Schraml; K Struckmann; R Bednar; W Fu; T Gasser; K Wilber; J Kononen; G Sauter; M J Mihatsch; H Moch
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

Review 3.  Molecular biology of lung cancer: clinical implications.

Authors:  Jill E Larsen; John D Minna
Journal:  Clin Chest Med       Date:  2011-10-07       Impact factor: 2.878

4.  Low-frequency loss of heterozygosity in Moloney murine leukemia virus-induced tumors in BRAKF1/J mice.

Authors:  J K Lander; H Fan
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

5.  A novel functional DEC1 promoter polymorphism -249T>C reduces risk of squamous cell carcinoma of the head and neck.

Authors:  Yu-Jing Huang; Jiangong Niu; Sheng Wei; Ming Yin; Zhensheng Liu; Li-E Wang; Erich M Sturgis; Qingyi Wei
Journal:  Carcinogenesis       Date:  2010-10-08       Impact factor: 4.944

6.  Recessive oncogenes: current status.

Authors:  Xiang Gao; Kenneth V Honn
Journal:  Pathol Oncol Res       Date:  1995       Impact factor: 3.201

Review 7.  Molecular and cellular biomarkers for field cancerization and multistep process in head and neck tumorigenesis.

Authors:  V A Papadimitrakopoulou; D M Shin; W K Hong
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

8.  Frequent loss of the short arm of chromosome 9 in resected non-small-cell lung cancers from Japanese patients and its association with squamous cell carcinoma.

Authors:  Y Kishimoto; K Sugio; T Mitsudomi; T Oyama; A K Virmani; D D McIntire; A F Gazdar
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

9.  Proteogenomic analysis of human chromosome 9-encoded genes from human samples and lung cancer tissues.

Authors:  Jung-Mo Ahn; Min-Sik Kim; Yong-In Kim; Seul-Ki Jeong; Hyoung-Joo Lee; Sun Hee Lee; Young-Ki Paik; Akhilesh Pandey; Je-Yoel Cho
Journal:  J Proteome Res       Date:  2013-12-06       Impact factor: 4.466

10.  Allelotype of squamous cell carcinoma of the head and neck: fractional allele loss correlates with survival.

Authors:  J K Field; H Kiaris; J M Risk; C Tsiriyotis; R Adamson; V Zoumpourlis; H Rowley; K Taylor; J Whittaker; P Howard
Journal:  Br J Cancer       Date:  1995-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.